Meta Description: Dr. Austin Harris, MD explains how ketamine infusion therapy in California is reshaping depression treatment through neuroplasticity and rapid brain healing.
California is facing a mental health crisis that traditional treatments haven't been able to solve for everyone. Across Los Angeles, Sherman Oaks, and communities throughout Southern California, thousands of people living with depression have tried antidepressant after antidepressant, only to find limited relief — or none at all. For these patients, a once-obscure anesthetic called ketamine is emerging as a genuine turning point, and few physicians understand its potential better than Dr. Austin Harris, a board-certified cardiothoracic anesthesiologist and founder of NeuroRelief Ketamine & Infusion Therapy in Sherman Oaks, CA.
Unlike conventional antidepressants that can take six to eight weeks to show any effect, ketamine has been shown to work within hours in many patients. That difference isn't just about speed — it points to a fundamentally different mechanism of healing, one rooted in the brain's own ability to rewire itself. This process, known as neuroplasticity, sits at the center of why ketamine infusion therapy has become one of the most talked-about developments in mental health care today.
What Is Neuroplasticity, and Why Does It Matter for Depression?
Neuroplasticity is the brain's natural capacity to form new neural connections, strengthen existing pathways, and adapt in response to experience, learning, or injury. For decades, scientists believed the adult brain was largely fixed after childhood. We now know that's untrue — the brain remains capable of meaningful structural change throughout life.
In depression, this adaptability appears to break down. Chronic stress and prolonged depressive episodes are associated with the loss of synaptic connections in areas of the brain responsible for mood regulation, memory, and decision-making, particularly the prefrontal cortex and hippocampus. Fewer connections often mean rigid, negative thought patterns become harder to escape. Austin Harris, MD frequently describes this to patients as the brain becoming "stuck in a groove" — unable to find new pathways out of despair.
How Ketamine Works Differently Than Traditional Antidepressants
Most conventional antidepressants, such as SSRIs, work by slowly increasing the availability of serotonin in the brain. Ketamine takes an entirely different route. It primarily targets NMDA receptors and influences the brain's glutamate system, the primary excitatory neurotransmitter network responsible for learning and memory.
This action triggers a cascade of events that promotes synaptogenesis — the rapid formation of new synapses, or connections, between neurons. Research published in outlets like Nature and studies from Yale University have shown that ketamine can restore synaptic density in brain regions weakened by chronic depression, essentially giving the brain fresh material to build healthier neural pathways.
"What we're really doing with ketamine isn't just masking symptoms," explains Dr. Austin Harris. "We're giving the brain a window of opportunity to rebuild the connections that depression has worn away." This is a key reason ketamine infusion therapy has drawn interest not just from patients, but from psychiatrists and researchers across the country, including many practicing throughout California.
Who Benefits Most: Treatment-Resistant Depression and Beyond
Ketamine therapy is not typically positioned as a first-line treatment. It's most often considered for patients diagnosed with treatment-resistant depression — generally defined as depression that hasn't responded adequately to at least two different antidepressant medications. For these individuals, who may have spent years cycling through medications and therapies with little improvement, ketamine can represent a meaningful shift.
Beyond major depressive disorder, ketamine has also shown promise for patients dealing with anxiety disorders, PTSD, certain chronic pain conditions, and, in select cases, substance use struggles. Dr. Harris has noted that his interest in ketamine's psychiatric benefits actually began in the operating room, long before he opened his private practice — observing how surgical patients with underlying mood disorders or opioid dependency responded uniquely well to ketamine as part of their anesthesia protocol.
What to Expect From Ketamine Infusion Therapy
Ketamine infusion therapy is typically administered in a monitored clinical setting, where a low, controlled dose is delivered intravenously over the course of about 40 minutes to an hour. Patients remain awake throughout the session, resting comfortably while vital signs are monitored by trained medical staff.
Most treatment protocols involve a series of infusions over several weeks, followed by maintenance sessions spaced out as needed based on how each patient responds. Effects can vary significantly from person to person — some notice a lift in mood within the first day or two, while others experience a more gradual improvement over the course of treatment.
It's worth emphasizing that ketamine infusion therapy is not a standalone cure. Providers like Austin Harris, MD generally recommend it as part of a broader, coordinated treatment plan that may include therapy, lifestyle changes, and ongoing psychiatric support. This general overview is educational in nature; anyone considering treatment should undergo a full clinical evaluation with a licensed provider to determine appropriateness, dosing, and protocol.
Why California Is at the Forefront of the Ketamine Therapy Movement
Southern California has become something of a hub for innovative, patient-centered mental health treatment — and ketamine infusion therapy is no exception. Several factors are driving demand across the state:
According to Dr. Austin Harris, this convergence of factors is exactly why he chose to base his practice in Sherman Oaks. "Southern California patients deserve access to treatments that are both medically rigorous and genuinely transformative," he says. "That's the standard we hold ourselves to every day."
About the Expert
Dr. Austin Harris is a board-certified cardiothoracic anesthesiologist. He completed his Anesthesiology residency at the University of California Irvine (UCI), and his Cardio-Thoracic Anesthesiology Fellowship at Keck Hospital of USC. Even before beginning his private practice, Dr. Harris was finding that ketamine, a rarely used anesthetic tool, could have profoundly positive outcomes when utilized with specific patients.
This sparked his in-depth research of ketamine's previously obscure properties, and its remarkable potential in treating patients suffering from mental health, chronic pain, and addiction struggles. Dr. Harris focused first on surgical patients presenting with unique mood, pain, and opioid dependency needs. Then, after perfecting these techniques at medical offices across Southern California, Dr. Harris formed NeuroRelief Ketamine & Infusion Therapy in Sherman Oaks, CA, to bring these successful results to the entire patient population. This much-needed service is now benefiting thousands of clients across the world.
Final Thoughts
The science behind ketamine and neuroplasticity offers real hope for the many Californians who have struggled to find relief through traditional depression treatments alone. As research continues to evolve, physicians like Dr. Austin Harris are helping bring this therapy into mainstream, medically supervised care — combining anesthesiology expertise with a deep commitment to mental health innovation.
Disclaimer: This article is intended for informational and educational purposes only and does not constitute medical advice. Ketamine infusion therapy should only be pursued under the guidance of a licensed medical provider following a comprehensive clinical evaluation. Individual results may vary.
